[1] It is intended for individuals with obesity, typically defined as a BMI of 30 kg/m or 27 kg/m with weight-related comorbidities, and is prescribed alongside dietary modifications and exercise
Obesity Three of the GLP-1 RAs are FDA approved for obesity: liraglutide (Victoza, Saxenda), semaglutide (Ozempic, Wegovy), and tirzepatide (Mounjaro, Zepbound) (these have separate brands for diabetes and obesity, and we have listed the diabetes brand first)
Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells
PlexusDx enables a precision-guided approach to affordability: lowest prices ($129$309/mo) combined with optional genetic context to ensure your cheapest option is also your most clinically aligned option
One of the simplest yet most effective ways to combat constipation is to increase water intake
Reduce portion sizes semaglutide slows gastric emptying, so large meals will sit heavily and increase nausea risk